SSJR’s Client Fertin Pharma Speaks at USPTO Technology Seminar to Educate Patent Examiners On Latest Technology
In a highly unusual occurrence, SSJR and its longtime client, Fertin Pharma, were invited by the United States Patent and Trademark Office to present a Technology Fair on the latest developments in chewing gum as a drug delivery system. These presentations to USPTO employees aid in increasing their general knowledge and expertise and keep them informed about new developments in their areas of expertise.
Fertin Pharma’s Senior Principal Scientist, Dr. Jesper Neergaard, presented an overview of chewing gum technology and the various design factors that must be considered especially when developing gum products to deliver drugs and other active ingredients, like nicotine. It is estimated more than 180 USPTO employees attended the seminar either live or via USPTO webcast. With Dr. Neergaard were Nicolai Kanved, Senior Manager IPR and Licensingfor Fertin Pharma, Jorgen Moeller, partner at Patentgruppen, Aarhus, Denmark, and Todd Oberdick and Richard Basile of SSJR.
This is another example of how SSJR’s close working partnership with its foreign agents and clients can lead to unusual and productive opportunities for SSJR clients.